Literature DB >> 10664603

Are cannabinoids endogenous ligands for the VR1 capsaicin receptor?

J Szolcsányi1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10664603     DOI: 10.1016/s0165-6147(99)01436-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  11 in total

1.  Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints.

Authors:  S D Gauldie; D S McQueen; R Pertwee; I P Chessell
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

2.  Effect of vanilloid drugs on gastrointestinal transit in mice.

Authors:  A A Izzo; R Capasso; L Pinto; G Di Carlo; N Mascolo; F Capasso
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  TRPV1 expression in acupuncture points: response to electroacupuncture stimulation.

Authors:  Therese S Abraham; Ming-Liang Chen; Sheng-Xing Ma
Journal:  J Chem Neuroanat       Date:  2011-01-20       Impact factor: 3.052

Review 4.  Cardiovascular pharmacology of cannabinoids.

Authors:  P Pacher; S Bátkai; G Kunos
Journal:  Handb Exp Pharmacol       Date:  2005

Review 5.  New insights on endocannabinoid transmission in psychomotor disorders.

Authors:  Andrea Giuffrida; Alexandre Seillier
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-04-10       Impact factor: 5.067

Review 6.  Vanilloid receptor ligands: hopes and realities for the future.

Authors:  A Szallasi
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors.

Authors:  You Shuei Lin; Lu-Yuan Lee
Journal:  J Physiol       Date:  2002-03-15       Impact factor: 5.182

Review 8.  Cannabinoids and neuroprotection.

Authors:  R I Grundy; M Rabuffetti; M Beltramo
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

9.  Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  J Physiol       Date:  2004-04-30       Impact factor: 5.182

10.  Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.

Authors:  Maria Grazia Morgese; Tommaso Cassano; Vincenzo Cuomo; Andrea Giuffrida
Journal:  Exp Neurol       Date:  2007-08-22       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.